306 related articles for article (PubMed ID: 9684289)
1. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
[TBL] [Abstract][Full Text] [Related]
2. Emergent issues in the genetics of intestinal neoplasia.
Dove WF; Gould KA; Luongo C; Moser AR; Shoemaker AR
Cancer Surv; 1995; 25():335-55. PubMed ID: 8718526
[TBL] [Abstract][Full Text] [Related]
3. Action of Min and Mom1 on neoplasia in ectopic intestinal grafts.
Gould KA; Dove WF
Cell Growth Differ; 1996 Oct; 7(10):1361-8. PubMed ID: 8891340
[TBL] [Abstract][Full Text] [Related]
4. Loss of Apc+ in intestinal adenomas from Min mice.
Luongo C; Moser AR; Gledhill S; Dove WF
Cancer Res; 1994 Nov; 54(22):5947-52. PubMed ID: 7954427
[TBL] [Abstract][Full Text] [Related]
5. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.
Koratkar R; Pequignot E; Hauck WW; Siracusa LD
Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
[TBL] [Abstract][Full Text] [Related]
7. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
Silverman KA; Koratkar R; Siracusa LD; Buchberg AM
Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834
[TBL] [Abstract][Full Text] [Related]
8. Expression of guanylin is downregulated in mouse and human intestinal adenomas.
Steinbrecher KA; Tuohy TM; Heppner Goss K; Scott MC; Witte DP; Groden J; Cohen MB
Biochem Biophys Res Commun; 2000 Jun; 273(1):225-30. PubMed ID: 10873591
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
10. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
[TBL] [Abstract][Full Text] [Related]
11. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
12. APC in the regulation of intestinal crypt fission.
Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA
J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477
[TBL] [Abstract][Full Text] [Related]
13. Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.
Haines J; Johnson V; Pack K; Suraweera N; Slijepcevic P; Cabuy E; Coster M; Ilyas M; Wilding J; Sieber O; Bodmer W; Tomlinson I; Silver A
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2868-73. PubMed ID: 15710876
[TBL] [Abstract][Full Text] [Related]
14. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
[TBL] [Abstract][Full Text] [Related]
15. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
Kettunen HL; Kettunen AS; Rautonen NE
Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
[TBL] [Abstract][Full Text] [Related]
16. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
[TBL] [Abstract][Full Text] [Related]
17. Mapping of multiple intestinal neoplasia (Min) to proximal chromosome 18 of the mouse.
Luongo C; Gould KA; Su LK; Kinzler KW; Vogelstein B; Dietrich W; Lander ES; Moser AR
Genomics; 1993 Jan; 15(1):3-8. PubMed ID: 8094372
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
Hassan AB; Howell JA
Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
[TBL] [Abstract][Full Text] [Related]
19. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism.
Fichera A; Guo Y; Romero L; Michelassi F; Arenas RB
J Surg Res; 1997 Apr; 69(1):188-92. PubMed ID: 9202668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]